MEDI 3 – TREN 200 by Meditech is a pharmaceutical-grade triple-ester Trenbolone blend combining Trenbolone Acetate, Trenbolone Enanthate, and Trenbolone Hexahydrobenzylcarbonate in a single oil-based injectable formulation at 200 mg/mL. The exclusive use of three distinct trenbolone esters with progressively extended release profiles represents a pharmacokinetically layered formulation strategy, documented in anabolic research literature for its capacity to deliver both rapid-onset and prolonged anabolic activity from a single compound across an extended dosing interval.
 
✔ Key Research Insights
Studied for its multi-phase pharmacokinetic profile, with trenbolone acetate contributing rapid-onset anabolic availability, trenbolone enanthate providing medium-duration sustained release, and trenbolone hexahydrobenzylcarbonate maintaining prolonged plasma trenbolone concentrations of up to 10 days in research subjects
Investigated for trenbolone's high androgen receptor binding affinity — documented at approximately five times that of testosterone in comparative steroid pharmacology research — and its associated effects on muscle density and nitrogen retention in clinical observations
Researched for its influence on nutrient partitioning efficiency and metabolic parameters in documented subject populations, a pharmacological characteristic frequently associated with trenbolone across anabolic research literature
Examined for its effects on lean mass preservation, recovery markers, and muscular endurance across extended anabolic research protocols
Documented for the continuous anabolic activity profile conferred by the triple-ester architecture, associated with minimized serum trenbolone fluctuation between administrations in pharmacokinetic research
Manufactured by Meditech to pharmaceutical-grade purity and precision blending standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: MEDI 3 – TREN 200
Molecules:
Trenbolone Acetate: 50 mg/mL
Trenbolone Enanthate: 100 mg/mL
Trenbolone Hexahydrobenzylcarbonate: 50 mg/mL
Total Concentration: 200 mg/mL
Appearance: Oil-based solution
Packing: Sterile 10 mL clear glass vial with red flip-off cap and labeled box
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
MEDI 3 – TREN 200 delivers three ester-modified forms of trenbolone simultaneously via intramuscular injection, each undergoing enzymatic hydrolysis at a distinct rate to release free trenbolone into systemic circulation across a staggered multi-phase timeline in research subjects. Trenbolone acetate, as the shortest-acting ester in the blend, undergoes rapid hydrolysis following administration, producing an early elevation of circulating trenbolone and establishing anabolic receptor activity within a compressed timeframe. Trenbolone enanthate, as a medium-to-long-acting ester, provides a sustained intermediate release phase, maintaining serum trenbolone concentrations across the mid-point of the dosing interval. Trenbolone hexahydrobenzylcarbonate — also referenced as trenbolone cyclohexylmethylcarbonate — is the longest-acting ester in the formulation, documented in pharmacokinetic research for its extended plasma half-life of up to 10 days, providing the final and most prolonged phase of trenbolone release. The resulting composite pharmacokinetic profile spans from near-immediate onset through sustained activity extending across an extended inter-dose interval, minimizing the serum concentration fluctuations associated with single-ester preparations. Trenbolone itself exerts its primary pharmacological effects through high-affinity androgen receptor binding in muscle and target tissues, with documented downstream influences on protein synthesis, nitrogen retention, and nutrient partitioning efficiency across research subject populations.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade purity and precision blending standards
Triple-ester exclusive trenbolone formulation with a pharmacokinetically layered rapid-to-prolonged release profile documented in comparative anabolic research
Three-phase anabolic activity spanning near-immediate onset through up to 10-day sustained plasma trenbolone concentrations within a single 200 mg/mL formulation
Supplied in a clearly labeled sterile glass vial with secure flip-off cap, consistent with pharmaceutical packaging standards
Widely referenced in anabolic pharmacology research under the trenbolone acetate, trenbolone enanthate, and trenbolone hexahydrobenzylcarbonate designations